Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    14767435 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug
Conditions: Asthma;   Allergy;   Allergic Rhinitis;   Rhinitis, Allergic, Seasonal
Intervention: Drug: Amb a 1-immunostimulatory oligodeoxyribonucleotide conjugate (AIC)

Indicates status has not been verified in more than two years